PT - JOURNAL ARTICLE AU - Jiang, Shan AU - Zhou, Daizhan AU - Wang, Yin-Ying AU - jia, Peilin AU - Wan, Chunling AU - Li, Xingwang AU - He, Guang AU - Cao, Dongmei AU - Jiang, Xiaoqian AU - Kendler, Kenneth S. AU - Tsuang, Ming AU - Mize, Travis AU - Wu, Jain-Shing AU - Lu, Yimei AU - He, Lin AU - Chen, Jingchun AU - Zhao, Zhongming AU - Chen, Xiangning TI - Identification of <em>de novo</em> mutations in prenatal neurodevelopment-associated genes in schizophrenia in two Han Chinese patient-sibling family-based cohorts AID - 10.1101/19011007 DP - 2019 Jan 01 TA - medRxiv PG - 19011007 4099 - http://medrxiv.org/content/early/2019/11/05/19011007.short 4100 - http://medrxiv.org/content/early/2019/11/05/19011007.full AB - Schizophrenia (SCZ) is a severe psychiatric disorder with a strong genetic component. High heritability of SCZ suggests a major role for transmitted genetic variants. Furthermore, SCZ is also associated with a marked reduction in fecundity, leading to the hypothesis that alleles with large effects on risk might often occur de novo. In this study, we conducted whole-genome sequencing for 23 families from two cohorts, Taiwan and Shanghai, with matched unaffected siblings and parents. Two nonsense de novo mutations (DNMs) in GJC1 and HIST1H2AD were identified in SCZ patients. By performing DNM-based burden test, we found that DPYSL2, NBPF1, SDK1, ZNF595, ZNF718, GCNT2, SNX9, AACS, KCNQ1 and MSI2 genes carried more DNMs in SCZ patients than their unaffected siblings. Developmental expression analyses revealed that the loss-of-function DNM genes and DNM-burdened genes showed significantly higher expression in prefrontal cortex in prenatal stage. The biased high expression of GJC1 and SDK1 in prenatal stage were preserved in other brain regions and conserved across species. Data from genome-wide association studies suggested that common variants in the GJC1, HIST1H2AD and SDK1 genes may contribute to the risks of SCZ and SCZ-related traits. Analyses on GJC1 revealed that genes co-expressed with GJC1 were involved in SCZ, SCZ-associated pathways and drug targets. GJC1 may be a potential target for SCZ in prenatal and early neurodevelopment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by grants from National Institutes of Health (R01MH101054 to X.C. R01LM012806 to Z.Z.) the National Natural Science Foundation of China (grant 81421061), the National Key Research and Development Program (2016YFC0906400), Shanghai Key Laboratory of Psychotic Disorders (13dz2260500), Cancer Prevention and Research Institute of Texas (CPRIT RR180012 to X.J.), and UT Stars award to X.J. The whole genome sequencing of samples from Taiwan cohort were supported by grant from National Institutes of Mental Health (1RO1-MH085560) to M.T..Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe whole genome sequencing data used in the manuscript can be accessed from NCBI. https://www.ncbi.nlm.nih.gov/bioproject/PRJNA551447